Safety and Immunogenicity of One Dose of an Inactivated Trivalent Sub-unit Influenza Vaccine Administered to Non-elderly Adult and Elderly Subjects
Clinical trial NCT01357265 · COMPLETED
Trial details
- NCT number
- NCT01357265
- Sponsor
- Novartis Vaccines
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2011-05-01
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.